Historical shareholding details of Bridgeway Capital Management, LLC holdings in Xilio Therapeutics Inc (XLO)

Monthly changes of Bridgeway Capital Management, LLC shareholding in Xilio Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Bridgeway Capital Management, Llc 71,081 0.14%
Jan 31, 2025 Bridgeway Capital Management, Llc 71,081 0.16%
Dec 31, 2024 Bridgeway Capital Management, Llc 71,081 0.14%
Dec 31, 2024 Bridgeway Capital Management, Llc 71,081 0.16%
Nov 30, 2024 Bridgeway Capital Management, Llc 71,081 0.16%
Oct 31, 2024 Bridgeway Capital Management, Llc 71,081 0.16%
Sep 30, 2024 Bridgeway Capital Management, Llc 71,081 0.16%
Sep 30, 2024 Bridgeway Capital Management, Llc 71,081 0.16%
Aug 31, 2024 Bridgeway Capital Management, Llc 71,081 0.16%
Jul 31, 2024 Bridgeway Capital Management, Llc 71,081 0.16%
Jun 30, 2024 Bridgeway Capital Management, Llc 71,081 0.16%
Jun 30, 2024 Bridgeway Capital Management, Llc 71,081 0.19%
May 31, 2024 Bridgeway Capital Management, Llc 71,081 0.19%
Apr 30, 2024 Bridgeway Capital Management, Llc 155,481 0.42%
Mar 31, 2024 Bridgeway Capital Management, Llc 71,081 0.19%
Mar 31, 2024 Bridgeway Capital Management, Llc 155,481 0.56%
Feb 29, 2024 Bridgeway Capital Management, Llc 110,481 0.40%
Jan 31, 2024 Bridgeway Capital Management, Llc 110,481 0.40%
Dec 31, 2023 Bridgeway Capital Management, Llc 155,481 0.42%
Dec 31, 2023 Bridgeway Capital Management, Llc 110,481 0.40%
Nov 30, 2023 Bridgeway Capital Management, Llc 110,481 0.40%
Oct 31, 2023 Bridgeway Capital Management, Llc 110,481 0.40%
Sep 30, 2023 Bridgeway Capital Management, Llc 110,481 0.40%
Sep 30, 2023 Bridgeway Capital Management, Llc 110,481 0.40%
Aug 31, 2023 Bridgeway Capital Management, Llc 110,481 0.40%
Jul 31, 2023 Bridgeway Capital Management, Llc 110,481 0.40%
Jun 30, 2023 Bridgeway Capital Management, Llc 110,481 0.40%
Jun 30, 2023 Bridgeway Capital Management, Llc 110,481 0.40%
May 31, 2023 Bridgeway Capital Management, Llc 110,481 0.40%
Mar 31, 2023 Bridgeway Capital Management, Llc 110,481 0.40%

View all ownership details of Xilio Therapeutics Inc